摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl (E)-4-[(2-thiophen-2-yl-1,3-thiazole-4-carbonyl)amino]but-2-enoate

中文名称
——
中文别名
——
英文名称
methyl (E)-4-[(2-thiophen-2-yl-1,3-thiazole-4-carbonyl)amino]but-2-enoate
英文别名
——
methyl (E)-4-[(2-thiophen-2-yl-1,3-thiazole-4-carbonyl)amino]but-2-enoate化学式
CAS
——
化学式
C13H12N2O3S2
mdl
——
分子量
308.4
InChiKey
AOAIDNVQWHLPPM-GORDUTHDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    20
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.15
  • 拓扑面积:
    125
  • 氢给体数:
    1
  • 氢受体数:
    6

文献信息

  • Screening methods for the binding affinity of chemical entities to biological molecules and NEDD4-1 inhibitors identified by the screening methods
    申请人:Northwestern University
    公开号:US10273208B2
    公开(公告)日:2019-04-30
    Disclosed are methods for preparing and screening for an inhibitor of the activity of a biological molecule having a catalytic or non-catalytic cysteine residue. The methods including preparing a library of candidate inhibitor molecules by conjugating an electrophile to a plurality of drug molecules where the library of candidate inhibitor molecules thus formed react with cysteine residues. The library of candidate inhibitor molecules then may be reacted with the biological molecule to identify those inhibitor molecule that react with the catalytic or non-catalytic cysteine residue of the biological molecule in order to identify an inhibitor of the biological molecule.
    本发明公开了制备和筛选具有催化或非催化半胱酸残基的生物分子活性抑制剂的方法。这些方法包括制备候选抑制剂分子库,方法是将亲电子体与多个药物分子共轭,由此形成的候选抑制剂分子库与半胱酸残基发生反应。然后可将候选抑制剂分子库与生物分子反应,以确定那些与生物分子的催化或非催化半胱酸残基反应的抑制剂分子,从而确定生物分子的抑制剂
  • SCREENING METHODS FOR THE BINDING AFFINITY OF CHEMICAL ENTITIES TO BIOLOGICAL MOLECULES AND NEDD4-1 INHIBITORS IDENTIFIED BY THE SCREENING METHODS
    申请人:NORTHWESTERN UNIVERSITY
    公开号:US20160016893A1
    公开(公告)日:2016-01-21
    Disclosed are methods for screening for the binding affinity of chemical entities to other bioactive molecules. The screened chemical entities may be utilized in pharmaceutical composition or therapeutic methods for treating disease or disorders associated with the bioactive molecules including NEDD4-1.
  • US9586890B2
    申请人:——
    公开号:US9586890B2
    公开(公告)日:2017-03-07
查看更多